CareDx Says Required Additional Reviews by Swedish, U.S. Auditors, Approval of Prospectus in Bid to Acquire Allenex AB Now Expected by March 7, 2016

CareDx, Inc.

today announced a revised timeline to the recommended public offer to the shareholders of Allenex AB

S+). The previously announced timeline was based on both the approval from the Swedish financial regulator and the planned publication of the prospectus on February 29, 2016. Following recent changes in the working capital financing available to CareDx post closing of the offer that need to be reflected in the prospectus and the associated required additional reviews by CareDx` Swedish and U.S. auditors, approval and publication of the prospectus is now expected to occur by March 7, 2016. It is estimated that the offer will be completed in April 2016.